What should Diabetics know about COVID-19?
COVID-19 is a highly infectious viral infection due to the Novel Coronavirus. The infection originated in Wuhan, China where it spread quickly. There are over 2,258,516 n people infected with the virus around the world and over 154,371 deaths. In India, there are 14,378 confirmed cases and 201 deaths. The virus is a new strain and countries around the world are unsure how to tackle and treat the virus.
The virus spreads via the droplets when an infected person coughs, sneezes, or talks. The virus can survive in the air and on solid surfaces for a few hours or days depending on the type of surface. If you touch a contaminated surface and then touch your nose, mouth, or eyes you can get infected. The virus is killed in the environment when the surface is wiped with an alcohol-based solution.
Most people experience mild to moderate symptoms and make a complete recovery. Symptoms of COVID-19 are:-
Muscle pain and headache
Fever
Dry Cough
Fatigue
Sore throat
Repeated shaking with chills
Loss of smell and taste
More severe symptoms may include:-
Pneumonia
Breathing difficulty
Diarrhea
Chest pain
Death
The World Health Organization has said patients with Type 1 or Type 2 diabetes are at a higher risk of serious infection if they contract the virus. People with diabetes have lower immunity levels. Your immune system protects you from infections. Diabetic patients may have other health problems such as high blood pressure, obesity, and heart disease. This will make you more susceptible to infections. Research showed that 22% of patients hospitalized in China with severe infections had diabetes.
Other than diabetes other high-risk categories are:-
cancer patients
Smokers
Bone marrow transplant or organ transplant patients.
Patients taking immune-suppression medications or steroids.
If you have AIDS or HIV.
Patients with chronic lung disease or you suffer from moderate or severe asthma.
Patients with chronic lung or kidney infections.
If you are over 65.
Your risks are higher if you don’t control your sugar levels. Higher sugar levels lower your immunity levels. Lower immunity levels make fighting the infection tougher. It is important to manage your diabetes more vigilantly in this period. Eat healthy meals, exercise indoors for at least 30 minutes. Exercise will improve your mental health as well. It is extremely important to have your medication on time. It is important to ensure you have insulin or glucose tablets handy. You can order your medicines at home in advance before your supply ends. You can monitor your sugar levels with blood tests at home or using a glucometer. Type 1 diabetic patients can either order urine tests or use urine ketone strips. If you feel your diabetic symptoms are worsening you can consult your doctor through video consultation.
It is extremely important to follow the precautions laid down by the government such as:-
Clean your hands with either soap or sanitizer frequently for at least 20 seconds.
Wear a mask when you are feeling unwell.
Sneeze or cough into tissues that must be disposed of properly.
Practice social distancing.
Clean and disinfect surfaces at home frequently.
Stay indoors as much as possible.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Top 5 Most Recently Viewed Articles
The Shift in Private Loan Markets This takes me back to when the dot-com bubble burst—remember the chaos? Anyway, S&P Dow Jones Indices, that big player in the index game, is making waves again with the launch of the S&P Lincoln Senior Debt Indices. It’s a partnership with Lincoln International, and it’s all about filling a desperate gap in the private loan sector....
Continue Reading
Empowering Gender Equity with a New Tool The Institute for Women's Policy Research (IWPR) has unveiled its latest innovative initiative, the State Policy Action Lab (State PAL). This interactive platform consolidates over 100 gender equity data indicators, tracks nearly 500 state-level legislative bills, and offers actionable policy recommendations all in one...
Continue Reading
P95's Strategic Acquisition: Enhancing Clinical Research Services P95 BV, a well-respected name in epidemiology and clinical solutions, has made a significant move by acquiring Assign DMB, a reputable clinical research organization. This acquisition is a crucial milestone for P95, which is known for its strong emphasis on vaccines and infectious diseases. It allows them...
Continue Reading
Transforming IT in Times of Change As we navigate through an ever-evolving landscape marked by economic uncertainties and regulatory challenges, the role of IT leadership has become more vital than ever. The latest research from Info-Tech Research Group reveals that IT departments possess the potential to transform crises into opportunities, becoming agents of positive...
Continue Reading
Versa Networks Achieves Top Ratings in CyberSecurity Solutions SANTA CLARA, Calif. -- Versa, recognized as a leader in Universal Secure Access Service Edge (SASE), has garnered significant achievements recently, with their Security Service Edge (SSE) and Zero Trust Network Access (ZTNA) both earning the prestigious “AAA” rating from CyberRatings.org, a reputable...
Continue Reading